Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Biotech
Kailera launches with $400M series A, 4 Chinese obesity drugs
Kailera has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China and $400 million in series A funds.
James Waldron
Oct 1, 2024 8:30am
Metsera allies with Amneal to lock down GLP-1 supply
Oct 1, 2024 6:01am
Rivus posts data to back up muscle-sparing obesity drug claims
Sep 30, 2024 11:09am
BioAge brings in $198M from IPO as obesity biotech joins Nasdaq
Sep 26, 2024 4:44am
BioAge eyes $180M from IPO, private placement for obesity trials
Sep 25, 2024 7:55am
Metsera GLP-1 data slice reveals 7.5% weight loss at 36 days
Sep 24, 2024 7:00am